fbpx

Congressional Briefing – Obesity: The Cost of No Coverage


Obesity is a chronic disease that increases risk of other serious health conditions such as heart disease, stroke, diabetes and certain cancers. With 4 out of 10 American adults living with obesity, access to and insurance coverage for treatment options is essential.

The Treat and Reduce Obesity Act (TROA) was reintroduced this Congress with the goal of expanding Medicare coverage to include screening for and treatment of obesity, as well as coverage of FDA-approved medications for chronic weight management. Similar legislation is being introduced at the state level as well.

Learn about the real-world impacts, including the economic toll, that a lack of obesity treatment coverage has on women.

Opening Remarks

Beth Battaglino, RN-C
President and CEO, HealthyWomen

Moderator

u200bElizabeth Garner, M.D., MPH

Elizabeth Garner, M.D., MPH
Immediate Past President, American Medical Women’s Association
Former Chief Scientific Officer, Ferring Pharmaceuticals

Speakers

u200bChad D. Meyerhoefer, Ph.D.

Chad D. Meyerhoefer, Ph.D.
Chair of the Department of Economics, Lehigh University
Research Associate, National Bureau of Economic Research

Thank you to our briefing co-sponsors:

Alliance for Patient Access
awhp logo
amwa logo
National Headache Foundation
oac logo
oma logo
weight watchers logo
women heart logo

This educational resource was created with support from Eli Lilly and Company.



Credit : Source Post

We will be happy to hear your thoughts

Leave a reply

Fitpeaklab.com
Logo
Shopping cart